The Canadian Investment Regulatory Organization (CIRO) has temporarily halted all trading of Silver Elephant Mining Corp. (TSX: ELEF) as of 9:22 AM ET on November 6, 2026. The halt is due to pending news that has not yet been disclosed, a common regulatory measure to maintain a fair and orderly market. Investors should await further announcements from the company for details before trading resumes.
Silver Elephant Mining Corp. trading halt is the subject, with Pluang market data for context. Of 83 Basic Materials US stocks on Pluang, 36 rose and 46 fell today. Notable movers include AUGO at USD 69.85 (-1.99%), CLF at USD 11.49 (+1.95%) with 100% sell orders, and TX at USD 47.70 (-1.93%). Data as of Nov 06, 2026 19:12 WIB.
BriaCell Therapeutics and its subsidiary BriaPro presented positive preclinical data at the SITC 2026 Annual Meeting, highlighting their immunotherapy platforms Bria-OTS+ and BP-80. Bria-OTS+ showed broad immune activation and sustained cancer cell k...
IMUNON, Inc. presented new data from its Phase 2 OVATION 2 trial showing that IMNN-001, combined with chemotherapy, significantly enhances anti-tumor T-cell immune responses in advanced ovarian cancer patients. This immune activation correlates with ...
Canary Capital has launched the Canary Staked INJ ETF (INJC) on Nasdaq, providing investors exposure to INJ, the native token of the Injective blockchain. The ETF not only tracks INJ's price but also earns staking rewards from the network's proof-of-...
The Ozempic market, valued at $30.04 billion in 2026, is projected to grow to $113.95 billion by 2032, with a CAGR of 24.89%. This growth is fueled by increasing demand for diabetes and metabolic health treatments, wider adoption of GLP-1 therapies, ...
Minerva Neurosciences announced its third quarter 2026 financial results and business updates, highlighting progress in its Phase 3 trial of roluperidone, a drug targeting negative symptoms of schizophrenia. The ongoing C19 study aims to confirm prio...
